| Patient | Jack London |
|---|---|
| Date of birth | 1987-01-12 |
| Identifiers | MRN HR-ET010-SYN; SSN (made up) 000-10-4482 |
| Document date | 2026-08-04 |
| Author | Eleanor Whitcombe-Ibe, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for establishing care for tiredness and ankle swelling, with high blood pressure and abnormal kidney tests, and heavy drinking found at the visit: kidney, liver and alcohol tests, AUDIT and DSM-5-TR assessment, withdrawal planning, mood and safety, his writing schedule, and a nephrology consultation. [S]
Sodium: 139 mmol/L; Potassium: 4.6 mmol/L; Bicarbonate (total CO2): 22 mmol/L; Urea nitrogen: 28 mg/dL (high); Creatinine: 1.98 mg/dL (high); Glucose: 94 mg/dL; eGFR (CKD-EPI 2021): 43 mL/min/1.73 m² (low); Urine albumin-to-creatinine ratio: 240 mg/g (high); Uric acid: 8.4 mg/dL (high); Calcium: 9.2 mg/dL; Phosphate: 3.8 mg/dL; Parathyroid hormone, intact: 74 pg/mL (high); Hemoglobin: 13.6 g/dL; MCV: 101 fL (high); Platelets: 182 10*3/uL; AST: 68 U/L (high); ALT: 41 U/L; GGT: 186 U/L (high); Albumin: 4.1 g/dL; Total bilirubin: 0.9 mg/dL; INR: 1; PEth (alcohol marker): 410 ng/mL (high); HbA1c: 5.4%; Total cholesterol: 214 mg/dL (high); HDL cholesterol: 58 mg/dL; LDL cholesterol (calculated): 128 mg/dL; Triglycerides: 140 mg/dL; AUDIT: 27; PHQ-9: 9; GAD-7: 7. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-08-04 | Body height | 173 | cm | S |
| 2026-08-04 | Body weight | 84.2 | kg | S |
| 2026-08-04 | Body mass index (BMI) [Ratio] | 28.1 | kg/m2 | S |
| 2026-08-04 | Systolic blood pressure | 158 | mm[Hg] | S |
| 2026-08-04 | Diastolic blood pressure | 98 | mm[Hg] | S |
| 2026-08-04 | Heart rate | 92 | /min | S |
| 2026-08-04 | Respiratory rate | 16 | /min | S |
| 2026-08-04 | Body temperature | 36.8 | Cel | S |
| 2026-08-04 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-08-04 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-08-04 | Potassium [Moles/volume] in Serum or Plasma | 4.6 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-08-04 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 22 | mmol/L | 22-29 mmol/L | Normal | S |
| 2026-08-04 | Urea nitrogen [Mass/volume] in Serum or Plasma | 28 | mg/dL | 7-20 mg/dL | High | S |
| 2026-08-04 | Creatinine [Mass/volume] in Serum or Plasma | 1.98 | mg/dL | 0.74-1.35 mg/dL | High | S |
| 2026-08-04 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-08-04 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 43 | mL/min/{1.73_m2} | 45 to 59 is G3a; 30 to 44 is G3b | Low | S |
| 2026-08-04 | Albumin/Creatinine [Mass Ratio] in Urine | 240 | mg/g | Below 30 mg/g A1; 30 to 300 A2; above 300 A3 | High | S |
| 2026-08-04 | Urate [Mass/volume] in Serum or Plasma | 8.4 | mg/dL | 4-8 mg/dL | High | S |
| 2026-08-04 | Calcium [Mass/volume] in Serum or Plasma | 9.2 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-08-04 | Phosphate [Mass/volume] in Serum or Plasma | 3.8 | mg/dL | 2.5-4.5 mg/dL | Normal | S |
| 2026-08-04 | Parathyrin.intact [Mass/volume] in Serum or Plasma | 74 | pg/mL | 15-65 pg/mL | High | S |
| 2026-08-04 | Hemoglobin [Mass/volume] in Blood | 13.6 | g/dL | 13-17 g/dL | Normal | S |
| 2026-08-04 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 101 | fL | 80-100 fL | High | S |
| 2026-08-04 | Platelets [#/volume] in Blood by Automated count | 182 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-08-04 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 68 | U/L | 10-40 U/L | High | S |
| 2026-08-04 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 41 | U/L | 9-46 U/L | Normal | S |
| 2026-08-04 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 186 | U/L | 8-61 U/L | High | S |
| 2026-08-04 | Albumin [Mass/volume] in Serum or Plasma | 4.1 | g/dL | 3.5-5 g/dL | Normal | S |
| 2026-08-04 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.9 | mg/dL | 0.2-1.2 mg/dL | Normal | S |
| 2026-08-04 | INR in Platelet poor plasma by Coagulation assay | 1 | {INR} | 0.9-1.1 | Normal | S |
| 2026-08-04 | Phosphatidylethanol [Mass/volume] in Blood | 410 | ng/mL | Below 20 ng/mL abstinence or light drinking; above 200 heavy drinking | High | S |
| 2026-08-04 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.4 | % | <=5.6% | Normal | S |
| 2026-08-04 | Cholesterol [Mass/volume] in Serum or Plasma | 214 | mg/dL | <=199 mg/dL | High | S |
| 2026-08-04 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 58 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-08-04 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 128 | mg/dL | <=129 mg/dL | Normal | S |
| 2026-08-04 | Triglyceride [Mass/volume] in Serum or Plasma | 140 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-08-04 | Total score [AUDIT] | 27 | {score} | S | ||
| 2026-08-04 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 9 | {score} | S | ||
| 2026-08-04 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 7 | {score} | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Naproxen 500 mg oral tablet twice daily, bought over the counter at full strength and taken most days for about two years for knee and back pain; stopped at intake | One tablet by mouth twice a day, self-directed | Oral route | 2024-08-01 to 2026-08-04 | stopped | S |
| Losartan 50 mg oral tablet once daily | One tablet by mouth every morning | Oral route | 2026-08-04 to 2026-09-15 | completed | S |
| Chlordiazepoxide 25 mg oral capsule, fixed five-day taper for alcohol withdrawal (four capsules on day 1, three on day 2, two on day 3, one on days 4 and 5), dispensed for five days only, with a daily telephone check | Up to one capsule four times a day on day 1, tapering to one a day by day 4; stop after day 5; no alcohol or driving | Oral route | 2026-08-04 to 2026-08-08 | completed | S |
| Thiamine 100 mg oral tablet once daily | One tablet by mouth daily | Oral route | 2026-08-04 | active | S |
| Acetaminophen 500 mg oral tablet, one or two tablets up to four times a day as needed for pain, no more than 2,000 mg in a day, in place of naproxen | One to two tablets by mouth every six hours as needed; no more than four tablets a day | Oral route | 2026-08-04 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Tiredness, ankle swelling and high blood pressure (158/98 mmHg) with a raised creatinine (1.98 mg/dL, eGFR 43) and albumin in the urine (240 mg/g), found at intake; a creatinine of 1.7 mg/dL at an insurance examination about fourteen months ago, by his account; chronicity and cause under evaluation with a nephrology consultation | active | confirmed | R94.4 | S — Synthetic presenting problem anchored to the documented kidney damage found in 1913; superseded when the consultation staged chronic kidney disease. |
| Alcohol use disorder, severe (seven DSM-5-TR criteria): a bottle of whisky or more most days for years, a morning drink to steady his hands, failed attempts to cut down, and drinking despite knowing it harms his health; AUDIT 27; PEth 410 ng/mL | active | confirmed | F10.20 | S — Synthetic modern diagnosis anchored to his own published account of heavy drinking; the criteria, scores and amounts are synthetic and are not a claim about his real drinking. |
| Daily self-directed naproxen for knee and back pain for about two years, stopped at intake; acetaminophen in its place | active | confirmed | Z79.1 | S — Synthetic medication history; the joint pain is anchored to the documented rheumatism of 1914, which is not given a diagnosis. |
| Cigarette smoking, about ten a day; not ready to stop while he stops drinking | active | confirmed | F17.210 | S — Synthetic tobacco use; a physician-author's suggestion of heavy tobacco use is recorded only as a retrospective claim. |